Emerging Financial Statements From 2010 to 2025

EWPI Stock  USD 0.0001  0.00  0.00%   
Emerging World's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Emerging World's valuation are provided below:
Market Capitalization
11.9 K
Earnings Share
(0)
We have found thirty-one available fundamental signals for Emerging World Pharma, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Emerging World Pharma prevailing fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year.
Check Emerging World financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emerging World's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 80.1 K or Total Revenue of 0.0, as well as many indicators such as . Emerging financial statements analysis is a perfect complement when working with Emerging World Valuation or Volatility modules.
  
Build AI portfolio with Emerging Stock
Check out the analysis of Emerging World Correlation against competitors.

Emerging World Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities4.5 M4.3 M3.6 M
Slightly volatile
Accounts Payable663.1 K631.5 K527.1 K
Slightly volatile
Total Liabilities4.5 M4.3 M3.6 M
Slightly volatile
Common Stock210.8 K349.3 K283 K
Slightly volatile
Total Assets1.6 M3.1 M2.5 M
Pretty Stable
Cash3203371.1 K
Slightly volatile
Short and Long Term Debt1.9 M3.7 MM
Pretty Stable
Total Current Assets3203371.1 K
Slightly volatile
Short Term Debt1.9 M3.7 MM
Pretty Stable
Intangible Assets179.7 K202.1 K220.4 K
Slightly volatile
Property Plant Equipment2.2 K2.5 K2.8 K
Slightly volatile
Long Term InvestmentsM3.1 M2.6 M
Slightly volatile

Emerging World Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative80.1 K138.8 K111.7 K
Slightly volatile
Non Recurring21.6 K20.6 K17.4 K
Slightly volatile

Emerging World Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock11.4 K12 K12.3 K
Slightly volatile
Net Borrowings991.6 K896.1 K802 K
Slightly volatile
Depreciation40.7 K45.8 K49.9 K
Slightly volatile
Change To Operating Activities33.9 K51.3 K43.2 K
Pretty Stable
Total Cash From Financing Activities679.2 K911.4 K743.4 K
Slightly volatile
Change To Netincome4.6 K5.1 K5.6 K
Slightly volatile
Change To Liabilities328.1 K312.5 K260.8 K
Slightly volatile

About Emerging World Financial Statements

Investors use fundamental indicators, such as Emerging World's revenue or net income, to determine how well the company is positioned to perform in the future. Although Emerging World's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year

Currently Active Assets on Macroaxis

When determining whether Emerging World Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Emerging World's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Emerging World Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Emerging World Pharma Stock:
Check out the analysis of Emerging World Correlation against competitors.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Drug Manufacturers - Specialty & Generic space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emerging World. If investors know Emerging will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emerging World listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0)
The market value of Emerging World Pharma is measured differently than its book value, which is the value of Emerging that is recorded on the company's balance sheet. Investors also form their own opinion of Emerging World's value that differs from its market value or its book value, called intrinsic value, which is Emerging World's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emerging World's market value can be influenced by many factors that don't directly affect Emerging World's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emerging World's value and its price as these two are different measures arrived at by different means. Investors typically determine if Emerging World is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emerging World's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.